KRAS inhibitors, approved
- PMID: 35121930
- DOI: 10.1038/s43018-021-00289-3
KRAS inhibitors, approved
Erratum in
-
Author Correction: KRAS inhibitors, approved.Nat Cancer. 2022 Apr;3(4):518. doi: 10.1038/s43018-022-00372-3. Nat Cancer. 2022. PMID: 35379985 No abstract available.
References
-
- Kim, D., Xue, J. Y. & Lito, P. Cell 183, 850–859 (2020). - DOI
-
- Li, C. et al. Science 374, https://doi.org/10.1126/science.abf1730 (2021).
-
- Lou, K. et al. Sci. Signal. 12, eaaw9450 (2019). - DOI
-
- Manchado, E. et al. Nature 534, 647–651 (2016). - DOI
-
- Koga, T. et al. J. Thorac. Oncol. 16, 1321–1332 (2021). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous